The US Food and Drug Administration (FDA) and Boston-based wearable maker Whoop are having a bit of a back-and-forth.
The spat was revealed in an FDA warning letter sent to Whoop CEO Will Ahmed on July 14.
According to that letter, on two separate days, May 15 and May 27, Ahmed